Gynecological cancer - Insights
Find out how our gynecological cancer panels evaluate genes with relevance to diagnosing and treating uterine, ovarian, and endometrial cancers.
Neuropathies - Mayo Clinic Laboratories
Our comprehensive approach evaluates specific antibodies associated with autoimmune or paraneoplastic neuropathies offering answers for patients.
Neurofilament Light Chain (NFLC) - Insights
Alicia Algeciras, Ph.D., describes Mayo Clinic Laboratories’ new blood test to detect NFLC, or neurofilament light chain protein. NFLC is a biomarker for several neurodegenerative conditions. The new assay can determine if a patient’s...
CNS Demyelinating Disease Testing - Mayo Clinic Laboratories
We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.
Colorectal Cancer NGS Testing - Mayo Clinic Laboratories
Our panel was designed to meet current guidelines and remain targeted enough to provide clinically actionable results.
Benign Hematology Testing - Mayo Clinic Laboratories
Our metabolic hematology laboratory is dedicated to providing accurate diagnoses and interpretations with an emphasis on clinical significance for your patients.
Learn about our full suite of leukemia testing protocols, including includes flow cytometry, chromosome, FISH, and molecular testing.
Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC, explain how Mayo Clinic Laboratories' multigene panel helps identify the cause of hereditary ataxia. Precise diagnosis of this complex movement disorder helps guide patient treatment...
Acute Myeloid Leukemia Testing - Mayo Clinic Laboratories
Find out how our clinically validated testing for acute myeloid leukemia can provide critical diagnostic, prognostic, and therapeutic information for physicians.
Focused Pharmacogenomics Panel [Test in Focus] - Insights
Ann Moyer, M.D., Ph.D., explains Mayo Clinic Labs’ new focused pharmacogenomics panel, a real-time, PCR-based testing approach that assesses 10 genes known for their drug-gene associations, to provide guidance on medication selection for...